News
Before definitive conclusions on the use of dexrazoxane can be made, especially in children, more high-quality research is needed. We conclude that if the risk of heart damage from anthracyclines is ...
Chronic kidney disease (CKD) and hypertension are common health problems among childhood cancer survivors with potentially life-threatening sequelae.
A groundbreaking multinational clinical trial, named RESILIENCE, is underway to test a promising new treatment aimed at ...
New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.
Accord shares how cardiovascular risk impacts long-term patient outcomes in cancer care and how many survivors are at an ...
Moleculin Biotech gets US FDA positive feedback on paediatric study plan for Annamycin in children with R/R AML: Houston Saturday, June 21, 2025, 15:00 Hrs [IST] Moleculin Biotech ...
Anthracyclines are highly effective medicines used in chemotherapy to treat several types of cancer, but they can have harmful effects on the heart, also known as cardiotoxicity. This can lead to ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
Anthracyclines are highly effective medicines used in chemotherapy to treat several types of cancer, but they can have harmful effects on the heart, also known as cardiotoxicity.
16d
TipRanks on MSNRace Oncology Successfully Doses First Patient in Phase 1 TrialRace Oncology Ltd. ( ($AU:RAC) ) has issued an announcement. Race Oncology announced the successful and safe dosing of the first patient with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results